Amra Ciric Alibegovic on Muck Rack

Amra Ciric Alibegovic

As seen in: BMJ Open, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amra Ciric

Contact Amra Ciric, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in England

|
By Melanie J. Davies, Amra Ciric Alibegovic, anders jensen, Pranav Kelkar
| BMJ Open Verified
Strengths and limitations of this study This study used data from the Clinical Practice Research Datalink Aurum database, which collates data from primary care practices in England, UK. Patients with type 1 diabetes or type 2 diabetes registered in the database who were initiating or switching to faster aspart or a rapid-acting insulin analogue (insulin lispro, insulin aspart or insulin glulisine) during the study period were included.
Open in Who Shared Issue with article?

Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial

|
By Elisabeth R. Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy
| The Lancet Verified
Insulin degludec (degludec) is a second-generation basal insulin with an improved pharmacokinetic–pharmacodynamic profile compared with first-generation basal insulins, but there are few data regarding its use during pregnancy. In this non-inferiority trial, we aimed to compare the efficacy and safety of degludec with insulin detemir (detemir), both in combination with insulin aspart (aspart), in pregnant women with type 1 diabetes.
Open in Who Shared View Duplicates (63) Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified